Comparing the Efficacy and Safety of Finerenone and Spironolactone in the Treatment of Primary Aldosteronism

Conditions:   Primary Aldosteronism;   Hypertension Interventions:   Drug: Finerenone;   Drug: Spironolactone Sponsors:   The Affiliated Nanjing Drum Tower Hospital of Nanjing University Medical School;   National Key Research and Development Program of China;   National Natural Science Foundation of China Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials